Opens in a new window Opens an external website Opens an external website in a new window
This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. Privacy Policy
Main content starts here
ScienceInsider
Science and Policy
ET
In January 2027, Democrats will gain control of both the U.S. Senate and House of Representatives.Kevin Carter/Getty Images
Table of contents
A version of this story appeared in Science, Vol 394, Issue 6825.Download PDF
Related article
Californians poised to approve controversial $8.4 billion initiative to fund immunology research
BY- Phie Jacobs
News
06 Nov 2026
1.0x
00:00
1.0x
Last week’s U.S. midterm elections have given Democrats large majorities in both chambers of the new Congress that convenes in January 2027. Democratic lawmakers say they will aggressively investigate President Donald Trump’s economic policies, the Iran war, and other steps his administration has taken since taking office in 2025. But it’s not clear whether efforts to blunt Trump’s moves to remake U.S. science will be a major part of that agenda.
Here’s a look at what many researchers want from the 120th Congress at a time when it has many other issues to tackle, Trump still wields the veto pen, and federal judges could have the final say. We’ve rated their chances of success on a sliding scale, on which no wish is either certain or absolutely out of the question.
Limit political oversight of federal grantmaking. This is probably the top short-term item on the community’s wish list. Last week, 116 scientific organizations (including AAAS, which publishes Science) wrote to congressional leaders asking them to retain language in a temporary spending bill expiring next month that prevents the White House Office of Management and Budget (OMB) from advancing its plan to make far-reaching changes to rules governing federal grants and contracts. The administration has proposed giving political appointees a much bigger say in deciding what research to fund, allowing agencies to terminate grants without cause, and restricting international collaborations. Tens of thousands of scientists objected to the proposed changes to what’s known as Uniform Guidance when OMB announced them on 29 May. Prospect: GOOD
Prevent cap on indirect costs. The government now reimburses universities and medical centers for costs associated with conducting federally funded research, at a rate negotiated by each institution. Shortly after Trump took office, the National Institutes of Health unilaterally slashed those reimbursement rates by roughly half, and other agencies later moved to cap indirect costs. Courts overturned those moves, saying the administration hadn’t followed proper procedures. And last year Congress blocked OMB from implementing new caps. Most observers now expect OMB to try a new approach. It may not leave Congress with grounds to intervene, and opponents will need new arguments if they go to court to contest OMB’s move. Prospect: FAIR
Regain congressional authority over research spending. The Constitution gives Congress the authority to set government funding levels, and historically a president’s annual budget request is merely a starting point for negotiations between lawmakers and the White House. But besides proposing to slash research spending, Trump has routinely ignored spending instructions from Congress when they involve activities he dislikes or feels are wasteful, including work on climate change, public health, social justice, and increasing workforce diversity. Universities have also had grants and contracts frozen because of alleged antisemitism and civil rights violations. Democrats have made reasserting Congress’s spending authority a top priority, although it’s not clear how hard they will fight to protect individual research agencies and specific programs. Legislators could also seek legal redress, and any case is likely to reach the Supreme Court, with the outcome difficult to predict. Prospect: UNCERTAIN
Achieve growth in research budgets. This week, Congress returned to continue work on spending legislation for the current 2027 fiscal year that started on 1 October. Negotiations have stalled over partisan disagreement about overall defense and civilian spending, and legislators may pass another temporary measure that holds spending at current levels and leaves it to the new Congress to reach a final compromise. Last year, the Republican-led Congress rejected most of Trump’s requests for drastic cuts to research. But it’s rare for Congress to hike spending for a particular research agency or discipline in the absence of a boost for all civilian programs. And given the $40 trillion budget deficit, such a boost is unlikely. Prospect: POOR
Restore the National Science Foundation’s (NSF’s) independence. In April, Trump fired all the members of the presidentially appointed National Science Board, which oversees NSF. It was one of many White House interventions at an agency that traditionally has enjoyed relative autonomy, including cutting its staff by 30%, reducing solicitations for grant proposals, eliminating its Social, Behavioral and Economic Sciences directorate, and elevating the status and budget of NSF’s newest directorate, which aims to commercialize new technologies such as artificial intelligence and quantum computing and boost cofunding from industry. The incoming Democratic chairs of the committees overseeing NSF have pledged to grill White House and agency officials on those and other decisions, but their ability to reverse them is limited. Meanwhile, the agency has been without even an acting director since April 2025. Prospect: POOR
Halt changes to the 2030 census. In August, the Census Bureau proposed eliminating noncitizens from the upcoming decennial tally of the U.S. population and removing questions about race and ethnicity. Scientific and civil rights groups have submitted more than 100,000 comments opposing the changes, and last week 16 Democratic senators asked the agency to withdraw the proposal. Critics say the Constitution requires counting every resident, and that excluding noncitizens would invalidate key metrics that influence how public funds are distributed, where businesses locate, and myriad other activities. The changes are seen as a prelude to a White House effort to add a citizenship question to the census, an idea the Supreme Court rejected before the 2020 census on procedural grounds. The high court may once again find itself the final arbiter. Prospect: UNCERTAIN
Promote high-tech immigration. The U.S. academic research enterprise is heavily dependent on foreign talent, especially students and scholars from China, and many of the country’s leading tech companies are run by executives born abroad. But the Trump administration has restricted legal immigration, and tensions between China and the United States have derailed proposals to make it easier for those earning advanced science and engineering degrees at U.S. universities to remain in the country. There is bipartisan agreement that the immigration system needs to be altered to help maintain a healthy economy and bolster innovation. But disagreements over how to manage the border and deal with undocumented immigrants have stood in the way. Prospects for reform likely declined this week with Trump’s selection of Stephen Miller, the architect of the administration’s immigration policies, as his new chief of staff. Prospect: POOR
Agree on how to create a Golden Age of Science. Many science leaders agree that the government’s current approach to supporting academic research, forged after World War II and wildly successful in establishing U.S. leadership in science, needs updating. In July, Trump’s science adviser, Michael Kratsios, delivered a 92-page recipe for spurring a new “Golden Age of Science” that essentially incorporates all of the president’s priorities, proposals, and changes to date. But some elements are controversial, and others appear to be placeholders, with few details. So consensus on how to achieve a new golden age remains elusive. Prospect: POOR
What’s next? How much of any agenda Democrats can enact will hinge on whether they can attract enough Republican support to fend off what are expected to be frequent veto threats from Trump. The political needs of the many moderate Democrats who defeated Republican incumbents by campaigning on improving health care, lowering prices, and fighting corruption will also be a factor. With the next elections just 2 years away, other issues, including science, may end up low on their agenda.
doi: 10.1126/science.zhk4uk0
Science and Policy
Trump administration
Jeff Mervis tries to explain how government works to readers of Science.
Can researchers bring order to the confusing world of AI ‘benchmarks’?
By
Ananya
To deter bioterrorism, U.S. imposes new rules on ordering synthetic DNA
By
Phie Jacobs
Researchers sue to block NSF from demolishing social science directorate
Amid the unprecedented upheaval in U.S. science, hard-hitting, trustworthy reporting has never been more important. As part of the AAAS mission, Science has built a global award-winning network of reporters and editors that independently cover the most important developments in research and policy.
Your tax-deductible contribution plays a critical role in sustaining this effort.
If, at any time, you would like to stop or make changes to your monthly gift, please contact the Philanthropy Office at philanthropy@aaas.org or 202-326-6636.
Help News from Science publish trustworthy, high-impact stories about research and the people who shape it. Please make a tax‑deductible gift today.